QUARTERLY FINANCIAL INFORMATION - Equity Statement (Details) - USD ($)	3 Months Ended						12 Months Ended
	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Common stock, shares outstanding (in shares)							12,072,836	10,842,271
Total shareholders’ equity	$ 19,870,965	$ 22,893,674	$ 26,742,353	$ 35,704,682	$ 44,766,664	$ 41,210,855	$ 10,085,355	$ 31,321,994	$ 45,173,173
Issuance of contingent consideration shares originally incorrectly recorded in Q2 2023							$ 1,820,857	$ 3,164,967
Common Stock
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Common stock, shares outstanding (in shares)	13,120,413	13,056,409	12,452,613	11,948,718	11,911,043	11,627,528	13,522,669	12,292,104	11,626,522
Total shareholders’ equity	$ 13,120	$ 13,056	$ 12,452	$ 11,949	$ 11,911	$ 11,628	$ 13,523	$ 12,292	$ 11,627
Stock issuance related to acquisition and contingent consideration (in shares)							833,357	555,390
Issuance of contingent consideration shares originally incorrectly recorded in Q2 2023							$ 898	$ 555
Additional Paid in Capital
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Total shareholders’ equity	87,575,340	86,775,991	84,861,365	82,375,477	83,769,588	79,335,877	88,389,756	84,189,965	78,425,081
Issuance of contingent consideration shares originally incorrectly recorded in Q2 2023							1,819,959	3,164,412
Accumulated Deficit
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Total shareholders’ equity	(55,671,953)	(51,849,831)	(46,085,922)	(35,042,807)	(27,558,168)	(26,679,983)	(66,272,382)	(40,834,721)	(25,580,045)
Treasury Stock
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Total shareholders’ equity	(12,045,542)	(12,045,542)	(12,045,542)	(11,639,937)	(11,456,667)	(11,456,667)	(12,045,542)	(12,045,542)	$ (7,683,490)
As Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Total shareholders’ equity	$ 24,162,197	$ 26,730,572	$ 30,258,675	$ 37,504,143	$ 46,251,429	$ 44,608,733	$ 20,070,606	$ 34,731,764
As Reported | Common Stock
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Common stock, shares outstanding (in shares)	13,120,413	13,056,409	12,388,389	11,948,718	11,911,043	11,627,528	13,522,669	12,220,593
Total shareholders’ equity	$ 13,120	$ 13,056	$ 12,388	$ 11,949	$ 11,911	$ 11,628	$ 13,523	$ 12,221
As Reported | Additional Paid in Capital
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Total shareholders’ equity	88,268,286	87,468,937	85,554,375	83,068,423	82,971,694	79,589,977	88,901,583	84,882,982
As Reported | Accumulated Deficit
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Total shareholders’ equity	(52,073,667)	(48,705,879)	(43,262,546)	(33,936,292)	(25,275,509)	(23,536,205)	(56,798,958)	(38,117,897)
As Reported | Treasury Stock
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Total shareholders’ equity	(12,045,542)	(12,045,542)	(12,045,542)	(11,639,937)	(11,456,667)	(11,456,667)	(12,045,542)	(12,045,542)
Restatement Adjustments
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Total shareholders’ equity	(4,291,232)	(3,836,898)	(3,516,322)	(1,799,461)	(1,484,765)	(3,397,878)	(9,985,251)	(3,409,770)
Adjustments to goodwill due to using incorrect share price at acquisition date for equity portion of acquisition price	(692,946)	(692,946)	(692,946)	(692,946)	(692,946)	(254,100)	(692,946)	(692,946)
Issuance of contingent consideration shares originally incorrectly recorded in Q2 2023			0
Various income statement adjustments on or prior to December 31, 2023	(3,598,286)	(3,143,952)	$ (2,823,376)	1,106,515	2,282,659	3,143,778	(9,473,424)	(2,716,824)
Restatement Adjustments | Common Stock
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Stock issuance related to acquisition and contingent consideration (in shares)			64,224
Issuance of contingent consideration shares originally incorrectly recorded in Q2 2023			$ 64
Restatement Adjustments | Additional Paid in Capital
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Adjustments to goodwill due to using incorrect share price at acquisition date for equity portion of acquisition price	(692,946)	(692,946)	(692,946)	(692,946)	(692,946)	(254,100)	(692,946)	(692,946)
Issuance of contingent consideration shares originally incorrectly recorded in Q2 2023			(64)
Adjustments to goodwill due to inaccurate goodwill calculation in initial Emerald purchase price accounting					1,490,840
Restatement Adjustments | Accumulated Deficit
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Various income statement adjustments on or prior to December 31, 2023	$ (3,598,286)	$ (3,143,952)	$ (2,823,376)	$ 1,106,515	$ 2,282,659	$ 3,143,778	$ (9,473,424)	$ (2,716,824)